As of Jan 16
| -2.42 / -2.57%|
The 20 analysts offering 12-month price forecasts for Incyte Corp have a median target of 145.00, with a high estimate of 173.00 and a low estimate of 106.00. The median estimate represents a +58.21% increase from the last price of 91.65.
The current consensus among 23 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.